In today’s ACT Brief, we examine how AI is enabling continuous trial monitoring and faster site decisions, how provider ...

TransCelerate BioPharma has released its 2025 annual report, titled The Power of Forward, outlining a year defined by continued digital adoption, regulatory collaboration, and expansion of pragmatic ...

Zubel: In terms of analytics and AI, faster clinical data monitoring is already achievable. Predictive modeling is improving, but accuracy remains a challenge, particularly in oncology.

Angela Zubel, chief development officer, Debiopharm, explains how AI-enabled site selection, patient allocation, and real-time data monitoring can reduce costs, shorten timelines, and limit ...

In today’s ACT Brief, we examine how AI is shifting from pilot programs into daily development workflows, how a new adoption ...

Angela Zubel, chief development officer, Debiopharm, discusses why 2026 marks a shift from AI pilots to broader operational ...

Findings from the VA’s Diuretic Comparison Project show pragmatic trial designs can achieve strong provider participation when burden is minimized and patient care remains the primary focus.

Angela Zubel, chief development officer, Debiopharm, explains how AI-enabled site selection, patient allocation, and real-time data monitoring can reduce costs, shorten timelines, and limit ...

Miriam Dervan, founder & CEO of mdgroup, discusses how patient-centered strategies rooted in empathy and advocacy engagement ...

In today’s ACT Brief, we examine new data on regional variation in clinical trial risk, why patient experience must move from ...

Mike Wenger, chief innovation officer at CRIO, explains how AI can responsibly support data quality and monitoring with ...

This is the Applied Clinical Trials Brief —your fast track to the latest insights shaping clinical operations and drug development.